Priya Meghrajani
Technical Product Manager · Talosix
Keeping patients at the heart of healthcare.
I'm Priya: healthcare problem-solver, product manager, mom, and happiest on a trail. I've cared for patients, studied how hospitals run, and now build clinical trial software at Talosix. Wherever I am, I start with the same question: who is this for, and how does it make their life better?
Now
Updated September 2026,
from Snohomish, WA
- Leading product for the next generation of the Talosix EDC — study setup, visit schedules, subject management, ePRO, safety, database lock and reporting.
- Designing AI-assisted study setup: upload a protocol, get a suggested study configuration a data manager can review and approve.
- Fresh back from SCDM 2026 in Raleigh, thinking about where AI truly reduces data-cleaning burden versus just moving the work upstream.
Journey
I started in healthcare as a clinician, not a coder.
2006
Clinical care
KEM Hospital, Mumbai
2016
Hospital administration
TISS, Mumbai
2018
Product Owner
Optum (UnitedHealth Group)
2019
Product Owner → Technical Product Manager
Talosix, Seattle
Work
What I've helped build
Seven years at Talosix, an AI-enabled clinical research platform used by sponsors, CROs and providers. Before that, CMS Risk Adjustment products at Optum.
Live at Talosix
Electronic Data Capture
Faster data entry for sites: from 50 minutes to under 10 per instrument.
Patient Screening
AI-assisted identification of eligible trial participants.
Patient Engagement
ePRO and surveys that patients complete from home.
Study management & reporting
Analytics dashboards and reporting for sponsors, CROs and sites.
Building now
Next-generation Talosix EDC
Rebuilding study setup through database lock around AI assistance, with a human in the lead.
AI-assisted study startup
Getting from protocol to a live study faster, with reviewable AI suggestions instead of blank forms.
Exploring, after SCDM 2026
Cutting data-cleaning burden, not moving it
Where AI actually removes work for data managers versus shifting it upstream.
Risk-proportionate design
Not every data point deserves equal scrutiny. Designing checks around what matters.
Fit-for-purpose data collection
Collect what the protocol needs, not everything that's possible.
Continuous evidence & monitoring
Governance designed in from the start, not assembled after the fact.
Fluent in 21 CFR Part 11, ICH GCP, HIPAA, CDISC, OMOP and FHIR. New to clinical trials? Start with the plain-English glossary →
What guides me
Clinical instincts, product decisions
01
Identify the right problem first
Everything downstream depends on framing the problem correctly. I spend disproportionate time here.
02
Fit for purpose, not comprehensive
Less is more. The best clinical software asks for exactly what the protocol needs.
03
Risk proportionality
Not every risk deserves equal weight, and treating them as if they do is its own kind of failure.
Writing
Field notes
What SCDM 2026 taught me about purpose
Lindsey Wahlstrom took the stage at SCDM 2026 to share an incredibly moving, heartbreaking story of her child's battle with a rare disease. Hearing her perspective—and her family's journey through clinical trials—reframe
FDAThe FDA and real-time clinical trials
The FDA recently announced real-time clinical trials. AstraZeneca and Amgen are already piloting trials that report endpoints and safety signals to the agency as they happen. Chief AI Officer Jeremy Walsh estimated this
Product managementThe cake-mix lesson for AI products
A housewife in 1950s America opens a box of General Mills cake mix.
Life · Mindful Miles
Wander, wonder, and evolve.
Backpacking the Enchantments
Four days, one lottery permit, and a pass that cannot be named.
Beyond the roadmap
- Lead Women in Global Health professional meetups
- Organize events for Women in Business
- Certified Scrum Product Owner · AWS Cloud Essentials
- Speak English, Hindi, Marathi and Sindhi
- Hiker, backpacker, cyclist and snowboarder; mom to Adamya and three cats
Let's connect
Building in clinical research, healthcare AI, or product? I'd love to trade notes.
hello@priyameghrajani.com